Immunocorrection of post-traumatic inflammatory complications in patients with fractures of the lower jaw

ВАК
elibrary
inLibrary
Google Scholar
doi
 
Выпуск:
CC BY f
36-41
8
2
Поделиться
Рахимов, З., & Раззаков, К. (2023). Immunocorrection of post-traumatic inflammatory complications in patients with fractures of the lower jaw. Стоматология, 1(1), 36–41. извлечено от https://inlibrary.uz/index.php/stomatologiya/article/view/20668
Crossref
Сrossref
Scopus
Scopus

Аннотация

То study the effect of local immunocorrective therapy on pathogenic microflora in patients with post-traumatic osteomyelitis.

Похожие статьи


background image

STOMATOLOGIYA

3.

Орехов

Д.Ю.

Клинико-биохимическое

обоснование оказания стоматологической помощи
пациентам,

получающим

гемодиализ:

Автореф.

дис. ... канд мед. наук. - М., 2009. - 28 с.

4. Усманова Ш.Р., Давлатова Д.Д. Дисфункция

эндотелиоцитов

у

больных

хроническим

генерализованным пародонтитом // Интернаука. -
2020.-№44.-С. 62-65.

5.

Усманова Ш.Р., Хаджиметов А.А., Комилов

Х.П. Оценка местного и гуморального иммунитета
у

больных

с

хроническим

пиелонефритом

//

Стоматология:

наука

и

практика,

перспективы

развития. Волгоград, 2021. - С. 221-222.

Цель:

определение

биомаркеров

ренального

поражения

почек

у

больных

хроническим

генерализованным пародонтитом.

Материал и методы:

под наблюдением были

58 пациентов с хронической болезнью почек, а

именно

с

тубулоинтерстициальным

поражением

почек,

госпитализированных

в

нефрологическое

отделение

клиники

ТГСИ

в

2018-2019

гг.

Контрольную группу составили 18 человек со
здоровой полостью рта, не имеющих патологии
почек.

Результаты:

чувствительным маркером

тубулоинтерстициального

поражения

почек

является уровень в слюне, крови и моче активности
лизоцима и липокалина-2.

Выводы:

маркеры проксимальных канальцев

почек

у

больных

позволили

предложить

лечебно-профилактические

мероприятия

при

тубулоинтерстициальном

поражении

почек,

направленные на улучшение качества жизни.

Ключевые слова:

хронический

генерализованный

пародонтит,

тубулоинтерстициальное

поражение

почек,

лизоцим, гипероксалурия, уратурия.

Maqsad:

surunkali generalize periodontit bilan

og’rigan bemorlarda buyrak buyrak shikastlanishining

Хирургическая

стоматология

biomarkerlarini aniqlash.

Material va usullar:

2018-2019 yillarda TSSI

klinikasining

nefrologiya

bo’limiga

yotqizilgan

surunkali

buyrak

kasalligi,

ya’ni

tubulointerstitial

buyrak shikastlanishi bilan kasallangan 58 nafar
bemor

kuzatuvda

olindi.

Nazorat

guruhi

og’iz

bo’shlig’i sog’lom va buyrak patologiyasi bo’lmagan

18 kishidan iborat edi.

Natijalar:

tubulointerstitial buyrak

shikastlanishining

sezgir

belgisi

tupurik,

qon

va

siydikdagi lizozim va lipokalin-2 faolligi darajasidir.

Xulosa:

bemorlarda buyrak proksimal

kanalchalarining markerlari hayot sifatini yaxshilashga
qaratilgan

tubulointerstitial

buyrak

shikastlanishi

uchun terapevtik va profilaktika choralarini taklif

qilish imkonini berdi.

Kalit so’zlar:

surunkali generalize periodontit,

tubulointerstitial

buyrak

kasalligi,

lizozim,

giperoksaluriya, uraturiya.

Objective:

To determine the biomarkers of renal

kidney damage in patients with chronic generalized
periodontitis.

Material and methods:

58 patients with chronic

kidney disease, namely, with tubulointerstitial kidney
damage, hospitalized in the nephrology department of
the TSSI clinic in 2018-2019, were under observation.
The control group consisted of 18 people with a
healthy oral cavity and no kidney pathology.

Results:

A sensitive marker of tubulointerstitial

kidney damage is the level of lysozyme and lipocalin-2

activity in saliva, blood and urine.

Conclusions:

Markers of the proximal tubules

of the kidneys in patients made it possible to

propose therapeutic and preventive measures for
tubulointerstitial kidney damage aimed at improving
the quality of life.

Key

words:

chronic

generalized

periodontitis,

tubulointerstitial

kidney

disease,

lysozyme,

hyperoxaluria, uraturia.

UDC: 616.716+616-001,5:616.31:616-036.82

IMMUNOCORRECTION OF POST-TRAUMATIC INFLAMMATORY COMPLICATIONS IN

PATIENTS WITH FRACTURES OF THE LOWER JAW

V7

Rakhimov Z.K., Razzakov Q.R.

Bukhara State Medical Institute

36


background image

ХИРУРГИЧЕСКАЯ СТОМАТОЛОГИЯ

Preparations containing bacterial lysates attract

the interest of many specialists in various fields
of medicine. A long study of the properties and
mechanism of action confirms their immunotropic
effect and indicates the absence of the formation
of

persistent

protective

immunity,

which allows

them to be attributed to immunostimulating drugs

[2,3,9,15.17].

Lysates are fragments of destroyed bacterial cells

that have lost their viability (and therefore cannot
cause infectious diseases), but retained the ability to
activate immunity [16].

Lysates stimulate both innate immunity (through an

increase in the activity of dendritic cells, macrophages,

natural killers, the synthesis of interferons, etc.) and

acquired immunity

(by increasing the activation

of antidiv production, increasing the activity of
lymphocytes) [10,14].

In the 1970s, the first works were published proving

the effectiveness of the use ofbacterial lysates to reduce
the frequency and severity of respiratory infections.

In the same years, lysates of nonspecific action were
developed, however, the first representatives of this
group (pyrogenal and prodigiosan) had pronounced
side effects [6,13]. Second-generation drugs have

been more successful in terms of efficacy and safety.
Among them are Broncho-Munal, Ismigen, Imudon.

The use of the drug Imudon causes a number of
cascading immune actions in the div [4,18].

In Peyer’s intestinal plaques, dendritic cells are

activated, which begin to capture and destroy any

pathogens. In this case, dendritic cells represent
antigens of pathogenic microorganisms to lymphocytes

[11,12]. The production of interferons (IFN) a and

p with virostatic activity occurs. The synthesis of
antibodies involved in antibacterial protection is
increasing.

Especially often, fractures of the lower jaw lead

to (PTOLJ) in patients with improper reposition of

fragments of the jaw, in the presence of bruxism, as

well as in patients with various concomitant diseases
- diabetes, tuberculosis, alcoholism, etc. All these

diseases are accompanied by immunodeficiency, and

this is very likely to become a trigger in development
(PTOLJ) [1].

The purpose of the study.

Study of the

effect

of local immunocorrective therapy on pathogenic
microflora in patients withpost-traumatic osteomyelitis
(PTOLJ).

Materials and Research Methods

One of the main problems facing specialists in

surgical dentistry in the field of treatment of fractures

of the lower jaw (FLJ) is a comparative assessment

of the microbial landscape of acute and chronic
osteomyelitis in the formation of (PTOLJ).

Studies conducted by Ergashev V.A. with 380

adults and 68 children diagnosed with acute and
chronic osteomyelitis showed the following.

Adult

patients

375

(98.7±0.6%)

received

conservative treatment, and 179 of them (47.2±2.6%)

received both conservative and surgical treatment.
A group of children (100.0%, n = 68) received

conservative treatment after hospitalization, and 23
of them (33.8±5.7%) underwent surgical treatment in
addition to conservative treatment.

In this case, radiological signs were revealed that

are characteristic of the pathogenesis of the formation
and development of the disease in acute and chronic
osteomyelitis. Age-related differences of these signs
in patients have not been determined in practice.

In the acute form of the disease, the spectrum of

pathogenic microorganisms (strains of 4 species) was

significantly lower than in the chronic form (strains
of 10 species), all positive bacteriological results
isolated pathogens in the form of monoculture. The

monoculture leader was

Staph, aureus,

followed by

Ps. aeruginosa

[8].

In

various

experimental

studies,

a

causal

relationship between the microbiological aspects of
the formation of acute and chronic post-traumatic

lower jaw osteomyelitis was determined. The leading
causative agents of osteomyelitis were identified, and
despite the presence of age-related differences, the

microbial landscape was essentially an association

of gram-positive cocci

(Staph, aureus

and

Staph,

epidermidis}

in leading positions, which coincides

with the literature on osteomyelitis and is consistent
with the general the trend in the occurrence of
pathogens of osteomyelitis.

It was noted that the part of patients of different

age groups taking immunocorrective drugs had a
small number of various complications, including

the transition of the phase of acute osteomyelitis to a

chronic form.

Immunostimulants contribute to the neutrophilic

and lymphocytic response of the div to antigens
contained in the preparations. In acute inflammations
and

infections,

a

neutrophilic

response

always

precedes a more specific lymphocytic one. In chronic

inflammation and infections, the role of neutrophils
is

insignificant

and

the

lymphocytic

response

predominates (infiltration of the focus of inflammation
by lymphocytes).

Non-specific

resistance

indices

(complement

components C3 and ceruloplasmin) were evaluated by

the immunochemical method, the level of circulating

37


background image

STOMATOLOGIYA

immune complexes (CIC), average molecular peptides

(AMP) in the blood, complement C3, phagocytic
neutrophil activity, and ceruloplasmin concentration.

The Results of the Study

Complex treatment with the use of the local

immunocorrecting drug Imudon allowed to reduce
the concentration of average molecular peptides AMP
(from 0.58±0.06 conventional units to 0.28±0.02
conventional units, p<0.05), the level of circulating
immune complexes CIC (with 78.1±5.12 conventional

units

to

34.8±3.12

conventional

units,

p<0.05),

ceruloplasmin concentration (from 39.6 ± 0.52 mg/
dl to 25.2±0.22 mg/dl). The level of complement C3

after treatment significantly increased compared to the
initial one (from 68.8±2.15 mg/dl - 101.6±5.62 mg/dl,

p<0.05).

For 5 years, 93 patients with (FLJ) aged 17 to 62

years old, 67 men and 26 women, were hospitalized.

Persons of a young age prevailed, only 8 men were
over the age of 50. 57 patients had unilateral (FLJ), 36
had bilateral.

The control group consisted of 31 practically

healthy people.

Among the observed patients, 68.3% of patients

were admitted to the hospital on the first day of the

disease, up to three days - 24.5%, the rest - later
than 3 days. Due to the late immobilization of

fragments of the lower jaw, a purulent-inflammatory

process developed in the fracture gap. The source of

purulent infection was a tooth with necrotic pulp or

a pathological process in the periapical tissues. In
cases of rapid elimination of the focus of infection,
adequate antimicrobial therapy and reliable fixation
of fragments, the inflammatory process was stopped.
With a delay in tooth extraction and the absence

of reliable immobilization of bone fragments, the
transition of acute traumatic osteomyelitis into a

purulent-destructive process was noted.

Traditionally,

orthopedic

immobilization

was

carried out using various modifications, individually
curved wire or standard tape tires with hook loops.
Drug therapy included antibacterial (ceftriaxone, sulfa
drugs), desensitizing, painkillers.

All patients were divided into 2 groups: group

1-42 patients who underwent traditional therapy,

group 2-51 patients who were additionally given the
immunocorrecting drug Imudon (before surgery).

Non-specific

resistance

indices

(complement

components C3 and ceruloplasmin) were evaluated by
the immunochemical method, the level of circulating
immune complexes (CIC), and average molecular

peptides (AMP) in the blood according to the method

of A. Gabrielyan (1981), phagocytic activity of

neutrophils (FAN).

The results are presented in table.

Dynamics of non-specific resistance indices in patients with (FLJ)

Table

Index

Control

1 group

2 group

Initially

14 days

Initially

14 days

AMP (con. unit)

0.28 ±0.06

0.58 ±0.06*

0.58 ±0.06*

0.58 ± 0.06 *

0.28 ± 0.02 **

CIC (con. unit)

39.2 ±2.4

78.1 ±5.11 *

8.1 ±5.12*

78.1 ±5.12*

34.8 ±3.12 **

Complement C3,
mg/dl

124.7 ±8.9

68.9 ±2.13 *

8.8 ±2.15*

68.8 ±2.15*

101.9 ±5.64*

Ceruloplasmin,
mg/dl

24.6 ±0.41

39.6 ±0.51 *

39.6 ±0.52*

39.6 ± 0.52 *

25.2 ± 0.22

FAN, %

27.7 ± 0.61

38.4 ±1.38*

38.6 ±1.37*

38.6 ±1.37*

28.8 ± 0.5

* — significance of differences compared with control, p <0.05; ** — significance of differences

compared with the initial value in the same group, p <0.05.

Initially, all the studied parameters in both groups

significantly differed from the control. High values of

the level of (AMP) in patients with (FLJ) indicated
an unfavorable clinical course of the inflammatory

process, since they have toxicity and thereby reduce

local resistance. The phagocytic activity of neutrophils

(FAN) in the observed patients was statistically
significantly (1.4 times) higher than in healthy

individuals and practically did not change in dynamics
in the 1st group. The level of (CIC) was initially more

than 2 times higher; under their influence, lysosomal

enzymes are released from neutrophils, this leads to

the activation of mediator carrier cells, which in turn
induces an acute inflammatory process.

There was a decrease in the level of complement

C3 in patients with (FLJ) by almost 2 times compared

with the control, which, apparently, was due to

“increased consumption” of the (CIC) against a

purulent-inflammatory

process.

Low

values

of

complement C3, which is responsible for immune

adhesion of the (CIC) and chemotaxis, contribute to
exocytosis of neutrophil granules and secretion of

38


background image

ХИРУРГИЧЕСКАЯ СТОМАТОЛОГИЯ

lysosomal hydrolases. Alteration of tissues with cell

breakdown during inflammation leads to an increase

in ceruloplasmin, which enhances the activation of the
lysosomal neutrophil complex.

After a course of therapy for 14 days, the level

of all the studied parameters in the 1st group did not
change compared to the initial one and significantly

exceeded the similar indicators in the control group.

In group 2, complex treatment with the use of the

immunocorrecting

drug

Imudon

significantly

and

significantly reduced the concentration of AMP (2

times), the level of the CIC - 2.3 times.

After the therapy, these indicators approached the

values in the control group. The level of complement
C3 increased after treatment, however, it remained

below the control values (101.6±5.62 mg/dl, in the

control 124.7±8.9 mg/dl (p <0.05).

The concentration of ceruloplasmin after treatment

decreased by 64%. Both indicators - ceruloplasmin

and FAN - after treatment in the 2nd group did not

differ from the control.

We

associated

all

the

results

with

the

immunostimulating effect of the drug Imudon, which

contains a mixture of bacterial lysates. The multivalent

antigenic complex of the drug Imudon corresponds

to pathogens that most often cause inflammatory

processes in the oral cavity.

Bacterial lysates have a number of specific

properties at all stages of the immune response, due

to which the effectiveness of their use is much higher.

The mechanism of action consists in stimulating the
processes of phagocytosis and antigen presentation,

enhancing

the

production

of

anti-inflammatory

cytokines (interleukin-4, interleukin-10, TGF), and

the development of an adjuvant effect. Moreover, this
mechanism is the most physiological, since bacterial

lysates stimulate the div’s own reactions to antigen
exposure and do not cause unnecessary additional

effects. Along with the production of specific antibodies
to the pathogens included in the preparations, they

also stimulate nonspecific immunity - the production
of

secretory IgA, interleukin-1

and a-interferon,

cytokines, NK cells, macrophage-phagocytic system

cells, etc. increase [5,7]

Conclusions

1.

Taking the drug Imudon activates antibacterial

immunity, helps to reduce the risk of bacterial
complications,

thereby

reducing

the

need

for

antibiotics.

2.

Imudon activates phagocytosis, increases the

number of immunocompetent cells, increases the
production of lysozyme and interferon, and IgA in

saliva. All this favors a sharp decrease in the incidence

rate (PTOLJ) in patients with fractures of the lower jaw,

or softens the course of post-traumatic osteomyelitis
in patients with severe immunodeficiency.

3.

However, despite the successes achieved with

treatment (PTOLJ) and other bone injuries,

it is

often not possible to minimize the possibility of

complications.

4.

Currently, scientific studies have proved that most

pathologies occur due to immunological disorders that

contribute to the appearance of complications or the

transition of the process to a chronic course.

References

1.

Пулатова

Ш.К.,

Рахимов

3.K.,

Камбарова

Ш.А.,

Хамитова

Ф.А.

Комплексное

патогенетическое лечение больных с разлитыми

флегмонами челюстно-лицевой области

И

Новый

день в медицине. — 2019. — №2 (26). — С. 121-125.

2.

Рахимов З.К., Махмудов Ж.К., Пулатова

Ш.К.

Современный

подход

в

комплексном

лечении

острых

одонтогенных

воспалительных

заболеваний челюстно-лицевой области // Биол. и

интегративная мед. - 2019. - №3. - С. 79-89.

3.

Рахимов З.К., Махмудов Ж.К., Пулатова

Ш.К.

Эффективность

комплексного

лечения

острых

одонтогенных

воспалительных

заболеваний челюстно-лицевой области // Биол. и

интегративная мед. - 2019. -№3. - С. 105-115.

4. Рахимов З.К., Пулатова Ш.К. Отдалённые

результаты

комплексного

лечения

больных

с

травматическим

остеомиелитом

при

переломах

нижней челюсти // Stomatologiya. — 2018. — №4

(73).-С. 15-18.

5.

Рахимов З.К., Пулатова Ш.К., Замонова

Г.Ш. Совершенствование схемы патогенетической
терапии переломов нижней челюсти с осложненным

течением // Вести. Совета мол. учёных и спец. -

Челябинск, 2015. - №2 (9). - С. 77-83.

6.

Рахимов З.К., Пулатова Ш.К., Камбарова

Ш.А.

Особенности

эффективности

лечения

воспалительных

осложнений

переломов

нижней

челюсти и принципы терапии // Новый день в

медицине. -2015. №1. - С. 61-65.

7.

Рахимов З.К., Пулатова Ш.К., Сафарова

М.С.

Отдалённые

результаты

применения

Вобэнзима

в

комплексном

лечении

гнойно­

воспалительных

осложнений

при

переломах

нижней

челюсти

//

Актуальные

вопросы

стоматологии:

Сб.

статей

Всерос.

науч.-практ.

конф.-Уфа, 2015.-С. 183-186.

8.

Рахимов З.К., Сулайманов С.Ф. Влияние

Вобэнзима на местный иммунитет у больных с

39


background image

STOMATOLOGIYA

переломами нижней челюсти // Стоматология. —
2015.-МЗ.-С. 42-45.

9.

Agarkov N.M., Gontarev S.N., Zelensky V.A.

et al. Mathematical prediction of the development of
phlegmon in acute odontogenic osteomyelitis of the

jaw in terms of blood and systemic immunity // Med.

Bui. North Caucasus. — 2018. - Vol. 1. - P. 62-65.

10.

Belovolova

R.A.,

Novosyadlaya

N.V.,

Novgorodsky S.V. Features of the immune status and

the possibility of immunocorrection in post-traumatic
inflammatory complications in patients with open
fractures of the lower jaw // Immunology. - 2002. -
Vol. 5S. -P. 287-293.

11. Hamraev S.J. Complex Treatment of Patients

with Various Forms of Sialadenosis // Academic
research in educational sciences. - 2021. - T. 2, №9.
-C. 858-863.

12.

Hamrayev S.J., Rakhimov Z.K. Evaluation

of the Functional State of Vascular Walls in Patients
with Diseases of the Salivary Glands // New Day in
Medicine. - 2021. -№3 (35). -P. 10-14.

13.

Ivanushko

T.P.,

Gankovskaya

L.V.,

Shamanaev S.V. et al. A. Study of the content of

defensins in patients with purulent - inflammatory
diseases of the maxillofacial region // Dentistry. -
2014.-Vol. 93, №2.-P. 23-26.

14.

Matrosov VI. EHF-therapy in the complex

treatment of acute purulent-inflammatory diseases of

the maxillofacial region: Dis. ... cand. of med. Sci. -

Vladivostok, 2002.

15.

Nikitin A.A., Lapshin V.P., Kosyakov M.N.,

Stuchilov V.A., Malychenko N.V. Modem methods of

diagnosis and treatment of odontogenic mediastinitis

// Rus. Otorhinolaryngol. - 2004. - №5. -P. 15-18.

16.

Pulatova Sh.K., Rakhimov Z.K. Estimation

of clinical course in complex treatment of lower jaw
fractures in patients with immuno correction // Wld J.
Pharmac. Res. - 2020. - Vol. 9, Issue 9. - P. 93-104.

17.

Rakhimov Z.K., Pulatova Sh.K., Kambarova

Sh.A., Kuldasheva V.B. Some aspects in treatment of

purulent inflammatory complications at the fraktures
of the bottom law with a preparation vobansim //
Actual problems in the treatment and prophylaxis of

dental diseases. - Bukhara, 2016. - P. 68-69.

18.

Robustova

T.G.

New

trends

during

odontogenic osteomyelitis of the jaw // Rus. Dent. J. -
2006. - №5.-P. 32-34.

Цель:

изучение влияния местной

иммунокорригирующей

терапии

на

патогенную

микрофлору

у

больных

посттравматическим

остеомиелитом.

Материал иметоды:

за5лет госпитализированы

93 пациента с

ФЛЖ

в возрасте от 17 до 62 лет, из

них 67 мужчин и 26 женщин. Преобладали лица
молодого возраста, только 8 мужчин были старше
50 лет. У 57 больных был односторонний

(ФЛС),

у

36 - двусторонний.

Результаты:

имудон

активирует

фагоцитоз,

увеличивает

количество

иммунокомпетентных

клеток,

увеличивает

продукцию

лизоцима

и

интерферона, а также IgA в слюне. Все это
способствует резкому снижению заболеваемости

у

больных

с

переломами

нижней

челюсти

или

смягчает

течение

посттравматического

остеомиелита

у

больных

с

выраженным

иммунодефицитом.

Выводы:

в настоящее время доказано,

что

большинство

патологий

является

следствием

иммунологических

нарушений,

способствующих

возникновению

осложнений

или

переходу

процесса в хроническое течение.

Ключевые

слова:

постгравматический

остеомиелит

нижней

челюсти,

одонтогенный

очаг,

патогенная

микрофлора,

Staph,

aureus,

иммуностимуляторы,

неспецифическая

резистентность

организма,

бактериальные

лизаты, фагоцитоз, иммунокомпетентные клетки,
репаративный остеогенез.

Objective:

То

study

the

effect

of

local

immunocorrective therapy on pathogenic microflora
in patients with post-traumatic osteomyelitis.

Material and methods:

93 patients with LVH

aged 17 to 62 years were hospitalized over 5 years,
including 67 men and 26 women. Young people

predominated, only 8 men were over 50 years old.
In 57 patients it was unilateral (FLS), in 36 it was
bilateral.

Results:

Imudon activates phagocytosis, increases

the number of immunocompetent cells, increases the
production of lysozyme and interferon, as well as IgA

in saliva. All this contributes to a sharp decrease in

morbidity in patients with fractures of the lower jaw
or softens the course of post-traumatic osteomyelitis

in patients with severe immunodeficiency.

Conclusions:

At present, it has been proven that

most pathologies are the result of immunological

disorders

that

contribute

to

the

occurrence

of

complications or the transition of the process to a
chronic course.

Key words:

post-traumatic osteomyelitis of the

mandible, odontogenic focus, pathogenic microflora,

Staph,

aureus,

immunostimulants,

nonspecific

resistance

of

the

organism,

bacterial

lysates,

phagocytosis,

immunocompetent

cells,

reparative

osteogenesis.

40


background image

ХИРУРГИЧЕСКАЯ СТОМАТОЛОГИЯ

Maqsad:

travmadan

keyingi

osteomielitli

bemorlarda

mahalliy

immunokorrektiv

terapiyaning

patogen mikrofloraga ta’sirini o’rganish.

Material va usullar:

17 yoshdan 62 yoshgacha

bo’lgan LVH bilan kasallangan 93 nafar bemor 5 yil

davomida kasalxonaga yotqizilgan, shu jumladan 67
erkak va 26 ayol. Yoshlar ustunlik qildi, atigi 8 nafari
50 yoshdan oshgan erkaklar edi. 57 bemorda bir
tomonlama, 36 bemorda ikki tomonlama edi.

Natijalar:

imudon

fagotsitozni

faollashtiradi,

immunokompetent

hujayralar

sonini

oshiradi,

lizozim va interferon, shuningdek, tupurikda IgA
ishlab chiqarishni oshiradi. Bulaming barchasi pastki

jag’ning sinishi bo’lgan bemorlarda kasallanishning

keskin

kamayishiga

yordam

beradi

yoki

og’ir

immunitet tanqisligi bo’lgan bemorlarda travmadan
keyingi osteomielit kursini yumshatadi.

Xulosa:

hozirgi vaqtda ko’pchilik patologiyalar

asoratlaming pay do bo’lishiga yoki jarayonning
surunkali

kursga

o’tishiga

yordam

beradigan

immunologik kasalliklar natijasi ekanligi isbotlangan.

Kalit so’zlar:

pastki jag’ning travmadan keyingi

osteomiyelitlari, odontogen fokus, patogen mikroflora,
Staph,

aureus,

immunostimulyatorlar,

organizmning

nospesifik

qarshiligi,

bakterial

lizatlar,

fagotsitoz,

immunokompetent hujayralar, reparativ osteogenez.

UDK: 616.314.17-008.1-089 (075.8)

«KOLLAPAN» MATERIALLARIDAN FOYDALANGAN HOLDA SURUNKALI

PERIODONTITLARNIJARROHLIK USULI BILAN DAVOLASH

Rahimov Z.Q., Abdullayev D.R.

Buxoro davlat tibbiyo tinstituti

Tishlami saqlashuchunqo ’ llaniladiganoperatsiyalar

- uzoq davom etuvchi surunkali periodontitda ildiz
uchi zararlangan qismini olib tashlash va periodontal

soxadan ildiz kanaliga reinfeksiyalanish jarayonini
oldini olish imkonini beradi. Surunkali periodontitni

jarroxlik usuli bilan davolashning asosiy vazifasi

tish funksiyasini saqlab qolish va suyak to’qimasini
tiklashdir. Ildiz uchi rezeksiyasidan keng foydalanish
va shilliq qavatdan kesma o’tkazishning zamonaviy
usulidan

foydalanish

granulyomektomiyadan

so’ng

suyak

nuqsonini

to’ldirish

uchun

osteoplastik

materiallardan foydalanish imkonini berdi. Tish ildiz
uchi rezeksiyasidan so’ng har doim ham bo’shliq
qon orqali yangi suyak to’qimasi bilan to’lmagan.
Ko’pincha

tiklanish

jarayoni

chandiq

shakllanishi

bilan davom etmaydi va yillar davomida kechadi.

5%

hollarda

suyak

nuqsoni

umuman

to’lmaydi.

Osteogenezni

rag’batlantirish

uchun

suyak

nuqsonida osteoplastik materiallardan depo yaratish
katta

ahamiyatga

ega.

Alloplastik

(biocompositic)

g’ovak

modda

“Kollapan“

kukun

ko’rinishidagi

gidroksiapatitdan iborat bir xil II tip kollagenli va
antibiotik (linkomitsin gidroxlorid, gentamitsin sulfat,
klofaran,

rifampitsin,

metronidazole)

tuzilishida

plastin,

granula

va

gelsimon

“intermedapatit“

shaklida

ishlab

chiqariladi.

Submikron

zarracha

kattaligi va yuqori o’ziga xos yuzali “Kollapan“
gidroksiapatit suyakning gidroksiapatitiga mos keladi.
Antibiotiklar

asta-sekin

15 kundan 20 kungacha

granulalardan

atrofdagi

to’qimalarga

chiqariladi.

“Kollapan” materiallari reparativ osteogenezga ijobiy
tasir ko’rsatadi, appozitsion suyak o’sishi uchun

yo’naltiruvchi

matritsa

ro’lini

o’ynaydi

va

uzoq

muddatli antimikrob tasir ko’rsatadi.

Tadqiqot maqsadi

Surunkali

periodontit

kasalliklariga

chalingan

bemorlami tashxislash va ulami xirurgik davolash
usullarinitakomillashtirish.“Kollapan”materiallaridan

foydalangan holda surunkali periodontitni jarrohlik
davolash natijalarini o’rganish.

Material va usullar

18 yoshdan 55 yoshgacha bo’lgan (o’rtacha yosh

- 34,1 yosh) 28 bemorda (10 erkak, 18 ayol) 33 tishni

jarrohlik

usuli

bilan

davolash

amalga

oshiriladi.

Bemorlaming yuqori jag’ida 29 (87,8%) va pastki

jag’ida 4 (12,2%) ildiz cho’qqisi rezeksiyasi amalga

oshirildi. Eng ko’p kesuvchi (66,6%) operatsiya
qilindi. So’rovda yuz va og’iz bo’shlig’ini tekshirish,
“sabachi” tishni o’rganish (tikiash sifati suniy toj,

yiring

yo’li,

cho’ntaklar,

harakatlami

baholash,

41

Библиографические ссылки

Пулатова Ш.К., Рахимов З.К., Камбарова Ш.А., Хамитова Ф.А. Комплексное патогенетическое лечение больных с разлитыми флегмонами челюстно-лицевой области И Новый день в медицине. — 2019. — №2 (26). — С. 121-125.

Рахимов З.К., Махмудов Ж.К., Пулатова Ш.К. Современный подход в комплексном лечении острых одонтогенных воспалительных заболеваний челюстно-лицевой области // Биол. и интегративная мед. - 2019. - №3. - С. 79-89.

Рахимов З.К., Махмудов Ж.К., Пулатова Ш.К. Эффективность комплексного лечения острых одонтогенных воспалительных заболеваний челюстно-лицевой области // Биол. и интегративная мед. - 2019. -№3. - С. 105-115.

Рахимов З.К., Пулатова Ш.К. Отдалённые результаты комплексного лечения больных с травматическим остеомиелитом при переломах нижней челюсти // Stomatologiya. — 2018. — №4 (73).-С. 15-18.

Рахимов З.К., Пулатова Ш.К., Замонова Г.Ш. Совершенствование схемы патогенетической терапии переломов нижней челюсти с осложненным течением И Вести. Совета мол. учёных и спец. -Челябинск, 2015. - №2 (9). - С. 77-83.

Рахимов З.К., Пулатова Ш.К., Камбарова Ш.А. Особенности эффективности лечения воспалительных осложнений переломов нижней челюсти и принципы терапии // Новый день в медицине. -2015. №1-г- С. 61-65.

Рахимов З.К., Пулатова Ш.К., Сафарова М.С. Отдалённые результаты применения Вобэнзима в комплексном лечении гнойновоспалительных осложнений при переломах нижней челюсти И Актуальные вопросы стоматологии: Сб. статей Всерос. иауч.-практ. конф.-Уфа, 2015.-С. 183-186.

Рахимов З.К., Сулайманов С.Ф. Влияние Вобэнзима на местный иммунитет у больных с переломами нижней челюети // Стоматология. — 2015.-М3.-С. 42-45.

Agarkov N.M., Gontarev S.N., Zelensky V.A. cl al. Mathematical prediction of the development of phlegmon in acute odontogenic osteomyelitis of the jaw in terms of blood and systemic immunity // Med. Bui. North Caucasus. — 2018. - Vol. 1. - P. 62-65.

Belovolova R.A., Novosyadlaya N.V., Novgorodsky S.V. Features of the immune status and the possibility of immunocorrection in post-traumatic inflammatory complications in patients with open fractures of the lower jaw // Immunology. - 2002. -Vol. 5S. -P. 287-293.

Hamraev S.J. Complex Treatment of Patients with Various Forms of Sialadcnosis // Academic research in educational sciences. - 2021. - T. 2, №9. -C. 858-863.

Hamrayev S.J., Rakhimov Z.K. Evaluation of the Functional State of Vascular Walls in Patients with Diseases of the Salivary Glands // New Day in Medicine. - 2021. -№3 (35). -P. 10-14.

Ivanushko T.P., Gankovskaya L.V., Shamanaev S.V. et al. A. Study of the content of defensins in patients with purulent - inflammatory diseases of the maxillofacial region // Dentistry. -2014.-Vol. 93, №2.-P. 23-26.

Matrosov VI. EHF-therapy in the complex treatment of acute purulent-inflammatory diseases of the maxillofacial region: Dis. ... cand. of med. Sei. -Vladivostok, 2002.

Nikitin A.A., Lapshin V.P., Kosyakov M.N., Stuchilov V.A., Malychenko N.V. Modem methods of diagnosis and treatment of odontogenic mediastinitis II Rus. Otorhinolaryngol. - 2004. - №5. -P. 15-18.

Pulatova Sh.K., Rakhimov Z.K. Estimation of clinical course in complex treatment of lower jaw fractures in patients with immuno correction // Wld J. Pharmac. Res. - 2020. - Vol. 9, Issue 9. - P. 93-104.

Rakhimov Z.K., Pulatova Sh.K., Kambarova Sh.A., Kuldasheva V.B. Some aspects in treatment of purulent inflammatory complications at the fraktures of the bottom law with a preparation vobansim // Actual problems in the treatment and prophylaxis of dental diseases. - Bukhara, 2016. - P. 68-69.

Robustova T.G. New trends during odontogenic osteomyelitis of the jaw // Rus. Dent. J. -2006. - №5.-P. 32-34.

inLibrary — это научная электронная библиотека inConference - научно-практические конференции inScience - Журнал Общество и инновации UACD - Антикоррупционный дайджест Узбекистана UZDA - Ассоциации стоматологов Узбекистана АСТ - Архитектура, строительство, транспорт Open Journal System - Престиж вашего журнала в международных базах данных inDesigner - Разработка сайта - создание сайтов под ключ в веб студии Iqtisodiy taraqqiyot va tahlil - ilmiy elektron jurnali yuridik va jismoniy shaxslarning in-Academy - Innovative Academy RSC MENC LEGIS - Адвокатское бюро SPORT-SCIENCE - Актуальные проблемы спортивной науки GLOTEC - Внедрение цифровых технологий в организации MuviPoisk - Смотрите фильмы онлайн, большая коллекция, новинки кинопроката Megatorg - Доска объявлений Megatorg.net: сайт бесплатных частных объявлений Skinormil - Космецевтика активного действия Pils - Мультибрендовый онлайн шоп METAMED - Фармацевтическая компания с полным спектром услуг Dexaflu - от симптомов гриппа и простуды SMARTY - Увеличение продаж вашей компании ELECARS - Электромобили в Ташкенте, Узбекистане CHINA MOTORS - Купи автомобиль своей мечты! PROKAT24 - Прокат и аренда строительных инструментов